Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
This clinical trial evaluates the relationship between C1q binding to HLA antibodies (measured in a solid-phase immunoassay) and the clinica…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Baricitinib for Post-HSCT Persistent Thrombocytopenia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating baricitinib for persistent thrombocytopenia after allogeneic hematopoietic stem cell transplantation; cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Apixaban in Thrombocytopenia [EARLY_Phase 1]
This is an early Phase 1 clinical trial update on apixaban in patients with thrombocytopenia, including Deep Vein Thrombosis and Pulmonary E…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Managed Access Programs for ETB115, Eltrombopag
Novartis reports that managed access programs for ETB115, the eltrombopag product, are available for treating thrombocytopenia.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation. [Phase 1]
A Phase 1 clinical trial evaluating the safety, efficacy, and pharmacokinetics of MegaLT Injection for treating refractory thrombocytopenia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion
A clinical study is evaluating outcomes of prothrombin complex concentrate (PCC) versus recombinant activated factor VIIa for trauma-associa…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. [Phase 2]
Phase 2 trial evaluating preoperative romiplostim to treat thrombocytopenia in patients undergoing cardiac surgery; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Luspatercept for Clonal Cytopenias of Uncertain Significance [Phase 2]
The entry notes an ongoing Phase 2 trial of luspatercept for clonal cytopenias of uncertain significance (CCUS) and related cytopenias such …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT [Phase 3]
Phase 3 study evaluating etamsylate to prevent bleeding versus placebo in patients undergoing hematopoietic stem cell transplantation; curre…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of Umbilical Cord Blood Therapy for cancer treatment-induced thrombocytopenia…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia [Phase 2]
Phase 2 trial evaluating selinexor as monotherapy in patients with JAK inhibitor-naïve myelofibrosis and thrombocytopenia is currently recru…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients [NA]
A research study investigating plasma biomarkers linked to fatigue in patients with thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis [NA]
This clinical trial is investigating anti-platelet antibodies detected with the MAIPA assay to demonstrate the autoimmune nature of thromboc…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia [Phase 2, Phase 3]
Qilu Pharmaceutical's QL0911 is being studied in Phase 2 and Phase 3 trials for cancer treatment-induced thrombocytopenia. The study is curr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis [Phase 4]
Phase 4 clinical trial update evaluating anticoagulation strategies in patients with cancer-associated thrombosis and thrombocytopenia, curr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Herombopag Treated T-DM1 Induced Platelet Reduction [Phase 2]
A Phase 2 clinical trial is evaluating herombopag to treat thrombocytopenia induced by T-DM1, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Platelet-Directed Whole Blood Transfusion Strategy for Malaria [NA]
This clinical trial update describes ongoing recruitment for a study evaluating a platelet-directed whole blood transfusion strategy for sev…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors [NA]
This clinical trials entry describes a multicenter, open-label randomized study evaluating Romiplostim N01 for chemotherapy- or chemoradioth…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients [NA]
A clinical trial investigating Romiplostim N01 for thrombocytopenia caused by cytotoxic chemotherapy in breast cancer patients; the study is…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 1]
Phase 1 clinical trial update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for cancer therapy-induced thrombocytopenia is curre…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: The Holistic Study [Phase 3]
The Holistic Study is a Phase 3 clinical trial sponsored by Ostfold Hospital Trust that is not yet recruiting to evaluate a treatment for th…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating Romiplostim N01 to treat thrombocytopenia in patients with solid tumors receiving radiotherapy-based reg…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Hematological Disorders in EHPVO Patients
A clinical trial update describes a study on hematological disorders in patients with Extrahepatic portal vein obstruction and thrombophilia…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Anti-CD38 Antibody Treating APS With Thrombocytopenia [Phase 2]
A Phase 2 clinical trial evaluating an anti-CD38 antibody for antiphospholipid syndrome with thrombocytopenia is currently recruiting in Chi…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Clinical Efficacy of Platelet Transfusion
This study is evaluating the efficacy of platelet transfusion in patients with thrombocytopenia and hematologic malignancies, and is current…